For providers
Provider resources
Resources designed to support your practice
Access resources to help understand the utility, value, and applicability of the Oncotype DX Breast Recurrence Score® test—and materials to use with patients.

Advancing patient care together
Oncotype DX Breast Recurrence Score® test welcome kit
Get everything your practice needs to get started with the Oncotype DX Breast Recurrence Score test, including key evidence and clinical insights, patient support resources, and much more.
Guidelines
TAILORx trial
The Trial Assigning Individualized Options for Treatment (Rx), TAILORx, is the largest randomized adjuvant breast cancer trial.
Pathology guidelines
PDF
Learn how to choose a tissue specimen for testing.
ASCO guidelines
ASCO strongly recommends use of the Oncotype DX Breast Recurrence Score test for all postmenopausal patients (>50 years) with HR+, HER2-negative invasive breast cancer regardless of nodal status and for premenopausal (≤50) patients with node-negative, HR+, HER2-negative invasive breast cancer.1
Forms
Test Requisition form
PDF
To place an Oncotype DX® order for a patient, please complete the Oncotype DX Breast Recurrence Score form through our Provider Hub . You may also print a form, complete it, and fax it to 866-444-0640.

Ordering a test for your patients is fast and easy
Order tests, access results, and receive updates through our Provider Hub.
Have questions?
Call us at 1 866-662-6897 .
References
- Andre F, Ismaila N, Allison KH, et al. Biomarkers for adjuvant endocrine and chemotherapy in early-stage breast cancer: ASCO guideline update. J Clin Oncol. 2022;40(16):1816-1837.